Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 15Gastrointestinal 5Thoracic 3CNS 3Sarcoma 2Other solid neoplasm 1Other 1Gynecologic 1Genitourinary 1Endocrine 1Dermatologic 1Breast 1

Conditions

Mucositis 7Obesity 6Polycystic Ovary Syndrome 3Stomatitis 2Head and Neck Neoplasms 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Myeloma 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Lipid Metabolism Disorders 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Hirsutism 1Endometrial Neoplasms 1Dyspnea 1Drug-Related Side Effects and Adverse Reactions 1Disease 1Diabetes Mellitus 1Colorectal Neoplasms 1

Interventions

Radiotherapy, Intensity-Modulated 1Cisplatin 1CBLB502 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Tongue Neoplasms × Other × Clear all
NCT01728480 2013-12-11

Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy

Roswell Park Cancer Institute

Phase 1 Withdrawn
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡